Articles:
Publications:

5 hours ago

China’s biotech firms challenge US with rapidly developing RAS-targeted cancer therapies

China’s biotech firms challenge US with rapidly developing RAS-targeted cancer therapies

When the shares of Revolution Medicines surged after the US biotech firm unveiled a landmark result – its drug nearly doubled the overall survival for late-stage pancreatic cancer patients to 13.2 months – investment banks and scientists flagged... Read more.

More from South China Morning Post

Turn on Transparency.
Hong Kong’s Paul Chan pledges second trip to Saudi Arabia to build Mideast ties
Owner: Joseph Tsai is the chairman of Alibaba Group More info
Turn on Transparency.
Canadian province prepares lawsuit against OpenAI after school mass shooting
Owner: Joseph Tsai is the chairman of Alibaba Group More info
Turn on Transparency.
BYD surpasses Tesla in global race; ‘do-or-die’ crisis in China’s market: 7 EV reads
Owner: Joseph Tsai is the chairman of Alibaba Group More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

Jul. 7, 2026
AFP Journalists in Turkey Go on Strike Over Pay as Union Cites Inflation Gap
Neutral | Owner: International Journalists Association
Jul. 7, 2026
Kuwait Steps up Battle Against AI-Driven Misinformation
Center-left | Owner: Ahmed Al-Jarallah
Jul. 7, 2026
Journalists Turn to Courts to Combat Censorship Fears After Senate Abandons Modern Press Freedom Framework in the Dominican Republic
Neutral | Owner: Dolores Vicioso

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more